Service-De-Piscine-R-D-R near Johnson Heights BC (2343 Result(s))

Since its beginning in 1992, Angiotech Pharmaceuticals, Inc. has evolved from a global specialty pharmaceutical company to a medical device company and more recently to a wound closure company. During its 'specialty pharmaceutical' days Angiotech developed a differentiated R&D effort that focused on drug-medical device combinations for implantable, surgical products and acute trauma applications – this is no longer a focus of Angiotech.

In 1994 Dr. Mike Charach became the first Board Certified Animal Dermatologist in Western Canada and thus becoming third Canadian Board Certified. Currently there are approximately 200 actively practicing Veterinary Dermatologists in North America. He received his Bachelor of Science degree in Zoology (Honours) at the University of Manitoba. Dr. Charach's Doctor of Veterinary Medicine degree was achieved from the Western College of Veterinary Medicine at the University of Saskatchewan in 1980.

APNA MOTORS LTD is a pre-owned vehicle dealership in Surrey, BC, offering a variety of cars at competitive prices.

Serving patients in Vancouver for over 12 years, Aquarius Chiropractic offers therapy for muscle, joint and nerve pain. Our doctors provide care for neck and back pain, headaches, sport related injuries, repetitive strain injuries, and recovery from surgery and accidents. We have been endorsed by Olympic athletes and coaches, and are committed to providing the same level of care to every patient. Contact us today for more info and become a new patient.

We are a clinical-stage pharmaceutical company discovering and developing novel oral drug candidates to treat inflammation and cancer. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Our lead product candidate, AQX-1125, has demonstrated broad anti-inflammatory activity in vitro and in vivo, and has successfully completed three clinical trials with over 100 patients enrolled to date. We are currently investigating AQX-1125 in two Phase 2 clinical trials, one for exacerbations related to Chronic Obstructive Pulmonary Disease, or COPD, and one for Bladder Pain Syndrome/Interstitial Cystitis, or BPS/IC. COPD and BPS/IC are debilitating chronic inflammatory diseases affecting millions of people worldwide.